BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20070764)

  • 1. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
    Lester SE; Wight RG
    Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
    Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
    Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of head and neck cancer with retinoids: a negative result.
    Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
    Busquets JM; García HA; Trinidad-Pinedo J; Baez A
    P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
    Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
    Wong LY; Wei WI; Lam LK; Yuen AP
    Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of treatment results for oral tongue cancer.
    Sessions DG; Spector GJ; Lenox J; Haughey B; Chao C; Marks J
    Laryngoscope; 2002 Apr; 112(4):616-25. PubMed ID: 12150512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological presentation of tongue cancers and early cancer treatment.
    Najeeb T
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
    Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
    Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
    Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
    Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of salvage surgery in organ preservation strategies in advanced head and neck cancer.
    Dequanter D; Lothaire P
    B-ENT; 2008; 4(2):77-80. PubMed ID: 18681202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
    Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
    Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.